Abstract:2186 A biomarker validation study has been being conducted in a Chinese population with occupational or environmental exposures to PAHs. So far, 106 subjects have been recruited from coke oven workers (workers), residents in a metropolitan area (residents), and gardeners in suburb (gardeners). All subjects were monitored twice for their personal exposures to PAHs. The biological samples were collected for measurements of 1-hydroxypyrene (1-OHP) in urine and identification of polymorphisms of genes encoding for metabolic enzymes, including CYP1A1, microsomal epoxide hydrolase (mEH), and GSTM1 in lymphocytes. The average personal exposure levels of pyrene, benz (a) anthracene (BaA) and benzo (a) pyrene (BaP) in exposed workers were 15.1 ± 48.2 μg/m3, 4.4 ± 8.3 μg/m3 and 4.3 ±9.9 μg/m3, respectively. The corresponding levels in residents were 0.057 ± 0.004 μg/m3, 0.034 ± 0.003 μg/m3 and 0.028 ± 0.002 μg/m3, and those in gardeners were 0.016 ± 0.017 μg/m3, 0.022 ± 0.011 μg/m3, and 0.011 ± 0.011 μg/m3 respectively. The conjugate of 1-OHP with glucuronide (1-OHP-G) is the predominant form of pyrene metabolite in urine and showed strong associations with exposures not only to pyrene but also to BaA, BaP, and total PAHs. Most importantly, a significant difference in 1-OHP-G was even detected between gardeners and residents with exposures to BaP at 0.011 and 0.028 μg/m3, suggesting that 1-OHP-G is a good marker that can be used for risk assessment of BaP exposure at ambient levels. Furthermore, multiple regression analyses of 1-OHP-G on PAHs exposure indicated that smoking was an important confounding factor on urinary 1-OHP-G level, especially when exposure to low level of environmental PAHs. The potential effects of gene polymorphisms on the formation of 1-OHP-G were examined based on either individual genotype or combination of genotypes of the four. However, none of the examinations showed any significant association of 1-OHP-G with polymorphisms of CYP1A1, mEH, GSTM1, and GSTT1 probably due to relatively small number of samples (supported by grants: OH007632; ES00260).

A sensitive GC–MS/MS method for the quantification of benzo[a]pyrene tetrol in urine

Measurement of urinary Benzo[a]pyrene tetrols and their relationship to other polycyclic aromatic hydrocarbon metabolites and cotinine in humans

Development of a sensitive method for the quantification of urinary 3-hydroxybenzo[a]pyrene by solid phase extraction, dansyl chloride derivatization and liquid chromatography-tandem mass spectrometry detection

High-Throughput Analysis of Selected Urinary Hydroxy Polycyclic Aromatic Hydrocarbons by an Innovative Automated Solid-Phase Microextraction

Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkers

Isotope Dilution nanoLC/ESI+-HRMS3 Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene

Comparison of urinary 3-hydroxybenzo(a)Pyrene (3-OHBaP) and trans-anti-7,8,9,10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)Pyrene (TetraolBaP) as biomarkers of exposure to carcinogenic BaP

Identification and Quantification of 1-Hydroxybutene-2-yl Mercapturic Acid in Human Urine by UPLC- HILIC-MS/MS As a Novel Biomarker for 1,3-Butadiene Exposure.

Development and validation of an HPLC-MS/MS method for the simultaneous analysis of volatile organic compound metabolites, hydroxylated polycyclic aromatic hydrocarbons, and 8-hydroxy-2'-deoxyguanosine in human urine

Derivatization Method for Sensitive Determination of 3-Hydroxybenzo[a]pyrene in Human Urine by Liquid Chromatography-Electrospray Tandem Mass Spectrometry

A realistic human skin model to study benzo[a]pyrene cutaneous absorption in order to determine the most relevant biomarker for carcinogenic exposure

Urinary 1-Hydroxypyrene Glucuronide: A Sensitive Exposure Marker of PAHs at Low Levels Encountered in Ambient Air

Quantification of urinary mono-hydroxylated metabolites of polycyclic aromatic hydrocarbons by on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry

Simultaneous determination of 14 urinary biomarkers of exposure to organophosphate flame retardants and plasticizers by LC-MS/MS

Study on Biomarkers for Polycyclic Aromatic Hydrocarbons Exposure

A Column-Switching LC–MS/MS Method for Simultaneous Quantification of Biomarkers for 1,3-Butadiene Exposure and Oxidative Damage in Human Urine

Analysis of Benzo [a] Pyrene in Tobacco Cigarette Smoke by Accelerated Solvent/Solid-Liquid-Solid Extraction Coupled with Gas Chromatography/Mass Spectrometry

Optimisation and validation of a HS-SPME-GC-IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits

Determination of Urinary Bromophenols (brps) As Potential Biomarkers for Human Exposure to Polybrominated Diphenyl Ethers (pbdes) Using Gas Chromatography-Tandem Mass Spectrometry (Gc-Ms/ms)

Determination of 3-Hydroxybenzo[a]pyrene Glucuronide/Sulfate Conjugates in Human Urine and Their Association with 8-Hydroxydeoxyguanosine

Determination of Benzo[a]pyrene in Cigarette Mainstream Smoke by Using Mid-Infrared Spectroscopy Associated with a Novel Chemometric Algorithm